Figure 3
From: Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer
Baseline MIC1 levels and change in PSA after chemotherapy as predictors of overall survival. (A) Kaplan–Meier analysis demonstrating that a baseline MIC1 level greater than the median confers a poorer overall survival. (B) Kaplan–Meier analysis of the relationship between a ⩾30% decline in PSA at 3 months after commencing chemotherapy and overall survival. (C) ROC curve revealing baseline MIC1 level is superior to maximal change in PSA within 3 months in predicting death within 12 months of commencing chemotherapy.
